[1] CARTWRIGHT J E, FRASER R, LESLIE K, et al. Remodelling at the maternal-fetal interface:relevance to human pregnancy disorders[J]. Reproduction,2010,140(6):803-813.
[2] BOSE P, KADYROV M, GOLDIN R, et al. Aberrations of early trophoblast differentiation predispose to pregnancy failure:lessons from the anti-phospholipid syndrome[J]. Placenta,2006,27(8):869-875.
[3] SALKER M, TEKLENBURG G, MOLOKHIA M, et al. Natural selection of human embryos:impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss[J/OL]. PLoS One,2010,5(4):e10287.
[4] KLAUBER N, ROHAN R M, FLYNN E, et al. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470[J]. Nat Med,1997,3(4):443-446.
[5] PRABHUDAS M, BONNEY E, CARON K, et al. Immune mechanisms at the maternal-fetal interface:perspectives and challenges[J]. Nat Immunol,2015,16(4):328-334.
[6] MOFFETT A, COLUCCI F. Uterine NK cells:active regulators at the maternal-fetal interface[J]. J Clin Invest,2014,124(5):1872-1879.
[7] TRIGGIANESE P, PERRICONE C, CHIMENTI M S, et al. Innate immune system at the maternal-fetal interface:mechanisms of disease and targets of therapy in pregnancy syndromes[J]. Am J Reprod Immunol,2016,76(4):245-257.
[8] HIRABAYASHI J, KASAI K. Human placenta beta-galactoside-binding lectin. Purification and some properties[J]. Biochem Biophys Res Commun,1984,122(3):938-944.
[9] AHMAD N, GABIUS H J, SABESAN S, et al. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3[J]. Glycobiology,2004,14(9):817-825.
[10] COMPAGNO D, JAWORSKI F M, GENTILINI L, et al. Galectins:major signaling modulators inside and outside the cell[J]. Curr Mol Med,2014,14(5):630-651.
[11] MAQUOI E, VAN DEN BRULE F A, CASTRONOVO V, et al. Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts[J]. Placenta,1997,18(5-6):433-439.
[12] TIRADO-GONZALEZ I, FREITAG N, BARRIENTOS G, et al. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy[J]. Mol Hum Reprod,2013,19(1):43-53.
[13] FISCHER I, REDEL S, HOFMANN S, et al. Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1[J]. Placenta,2010,31(9):825-832.
[14] JESCHKE U, KARSTEN U, WIEST I, et al. Binding of galectin-1(gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody[J]. Histochem Cell Biol,2006,126(4):437-444.
[15] FISCHER C, SANCHEZ-RUDERISCH H, WELZEL M, et al. Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27[J]. J Biol Chem,2005,280(44):37266-37277.
[16] FISCHER I, WEBER M, KUHN C, et al. Is galectin-1 a trigger for trophoblast cell fusion?:the MAP-kinase pathway and syncytium formation in trophoblast tumour cells BeWo[J]. Mol Hum Reprod,2011,17(12):747-757.
[17] FISCHER I, SCHULZE S, KUHN C, et al. Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo[J]. Placenta,2009,30(12):1078-1082.
[18] GEORGIADIS V, STEWART H J, POLLARD H J, et al. Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration[J]. Dev Dyn,2007,236(4):1014-1024.
[19] ROLAND C S, HU J, REN C E, et al. Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia[J]. Cell Mol Life Sci,2016,73(2):365-376.
[20] COUTIFARIS C, KAO L C, SEHDEV H M, et al. E-cadherin expression during the differentiation of human trophoblasts[J]. Development,1991,113(3):767-777.
[21] HUTTER S, MORALES-PRIETO D M, ANDERGASSEN U, et al. Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells[J]. Cell Adh Migr,2016,10(1-2):28-38.
[22] VICOVAC L, JANKOVIC M, CUPERLOVIC M. Galectin-1 and -3 in cells of the first trimester placental bed[J]. Hum Reprod,1998,13(3):730-735.
[23] JAMES J L, STONE P R, CHAMLEY L W. Cytotrophoblast differentiation in the first trimester of pregnancy:evidence for separate progenitors of extravillous trophoblasts and syncytiotrophoblast[J]. Reproduction,2005,130(1):95-103.
[24] LIU A X, JIN F, ZHANG W W, et al. Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss[J]. Biol Reprod,2006,75(3):414-420.
[25] KOLUNDZIC N, BOJIC-TRBOJEVIC Z, KOVACEVIC T, et al. Galectin-1 is part of human trophoblast invasion machinery-a functional study in vitro[J/OL]. PLoS One,2011,6(12):e28514.
[26] KOLUNDZIC N, CUJIC D, ABU R T, et al. Galectin signature of the choriocarcinoma JAr cells:Galectin-1 as a modulator of invasiveness in vitro[J]. Mol Reprod Dev,2015,82(10):765-773.
[27] AL-SHAMI R, SORENSEN E S, EK-RYLANDER B, et al. Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway[J]. J Cell Biochem,2005,94(6):1218-1233.
[28] XIA J, QIAO F, SU F, et al. Implication of expression of osteopontin and its receptor integrin alphanubeta3 in the placenta in the development of preeclampsia[J]. J Huazhong Univ Sci Technolog Med Sci,2009,29(6):755-760.
[29] ERIKSON D W, BURGHARDT R C, BAYLESS K J, et al. Secreted phosphoprotein 1(SPP1, osteopontin) binds to integrin alpha v beta 6 on porcine trophectoderm cells and integrin alpha v beta 3 on uterine luminal epithelial cells, and promotes trophectoderm cell adhesion and migration[J]. Biol Reprod,2009,81(5):814-825.
[30] MOISEEVA E P, WILLIAMS B, GOODALL A H, et al. Galectin-1 interacts with beta-1 subunit of integrin[J]. Biochem Biophys Res Commun,2003,310(3):1010-1016.
[31] BEVAN B H, KILPATRICK D C, LISTON W A, et al. Immunohistochemical localization of a beta-D-galactoside-binding lectin at the human maternofetal interface[J]. Histochem J,1994,26(7):582-586.
[32] VON WOLFF M, WANG X, GABIUS H J, et al. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation[J]. Mol Hum Reprod,2005,11(3):189-194.
[33] JESCHKE U, WALZEL H, MYLONAS I, et al. The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding[J]. J Histochem Cytochem,2009,57(9):871-881.
[34] BOJIC-TRBOJEVIC Z, JOVANOVIC K M, KOLUNDZIC N, et al. Interaction of extravillous trophoblast galectin-1 and mucin(s)-Is there a functional relevance?[J]. Cell Adh Migr,2016,10(1-2):179-188.
[35] OZEKI Y, MATSUI T, YAMAMOTO Y, et al. Tissue fibronectin is an endogenous ligand for galectin-1[J]. Glycobiology,1995,5(2):255-261.
[36] WEINTRAUB A S, LIN X, ITSKOVICH V V, et al. Prenatal detection of embryo resorption in osteopontin-deficient mice using serial noninvasive magnetic resonance microscopy[J]. Pediatr Res,2004,55(3):419-424.
[37] HERINGTON J L, BANY B M. The conceptus increases secreted phosphoprotein 1 gene expression in the mouse uterus during the progression of decidualization mainly due to its effects on uterine natural killer cells[J]. Reproduction,2007,133(6):1213-1221.
[38] KOOPMAN L A, KOPCOW H D, RYBALOV B, et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential[J]. J Exp Med,2003,198(8):1201-1212.
[39] THIJSSEN V L, HULSMANS S, GRIFFIOEN A W. The galectin profile of the endothelium:altered expression and localization in activated and tumor endothelial cells[J]. Am J Pathol,2008,172(2):545-553.
[40] THIJSSEN V L, RABINOVICH G A, GRIFFIOEN A W. Vascular galectins:regulators of tumor progression and targets for cancer therapy[J]. Cytokine Growth Factor Rev,2013,24(6):547-558.
[41] THIJSSEN V L, BARKAN B, SHOJI H, et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity[J]. Cancer Res,2010,70(15):6216-6224.
[42] HSIEH S H, YING N W, WU M H, et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells[J]. Oncogene,2008,27(26):3746-3753.
[43] FREITAG N, TIRADO-GONZALEZ I, BARRIENTOS G, et al. Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia[J]. Proc Natl Acad Sci U S A,2013,110(28):11451-11456.
[44] CAMBY I, LE MERCIER M, LEFRANC F, et al. Galectin-1:a small protein with major functions[J]. Glycobiology,2006,16(11):137r-157r.
[45] FERREIRA L M, MEISSNER T B, TILBURGS T, et al. HLA-G:at the interface of maternal-fetal tolerance[J]. Trends Immunol,2017,38(4):272-286.
[46] BLOIS S M, ILARREGUI J M, TOMETTEN M, et al. A pivotal role for galectin-1 in fetomaternal tolerance[J]. Nat Med,2007,13(12):1450-1457.
[47] ILARREGUI J M, CROCI D O, BIANCO G A, et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10[J]. Nat Immunol,2009,10(9):981-991.
[48] ALUVIHARE V R, KALLIKOURDIS M, BETZ A G. Regulatory T cells mediate maternal tolerance to the fetus[J]. Nat Immunol,2004,5(3):266-271.
[49] WU M, LIU P, CHENG L. Galectin-1 reduction and changes in T regulatory cells may play crucial roles in patients with unexplained recurrent spontaneous abortion[J]. Int J Clin Exp Pathol,2015,8(2):1973-1978.